UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Rxsight Inc (RXST)

Rxsight Inc (RXST)
26.59 -0.27 (-1.01%) 03/05/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 26.59 unch (unch) 16:02 ET
Quote Overview for Wed, Mar 5th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
26.32
Day High
27.08
Open 26.95
Previous Close 26.86 26.86
Volume 361,500 361,500
Avg Vol 535,095 535,095
Stochastic %K 6.88% 6.88%
Weighted Alpha -57.22 -57.22
5-Day Change -2.38 (-8.22%) -2.38 (-8.22%)
52-Week Range 26.17 - 66.54 26.17 - 66.54
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,087,588
  • Shares Outstanding, K 40,491
  • Annual Sales, $ 139,930 K
  • Annual Income, $ -27,460 K
  • EBIT $ -37 M
  • EBITDA $ -42 M
  • 60-Month Beta 1.22
  • Price/Sales 7.79
  • Price/Cash Flow N/A
  • Price/Book 3.86

Options Overview Details

View History
  • Implied Volatility 55.31% ( -4.20%)
  • Historical Volatility 35.65%
  • IV Percentile 44%
  • IV Rank 14.27%
  • IV High 153.08% on 08/05/24
  • IV Low 39.03% on 05/22/24
  • Put/Call Vol Ratio 194.25
  • Today's Volume 781
  • Volume Avg (30-Day) 261
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 7,785
  • Open Int (30-Day) 5,788

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.15
  • Number of Estimates 3
  • High Estimate -0.10
  • Low Estimate -0.18
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.17 +1.60%
on 03/04/25
Period Open: 34.26
34.64 -23.24%
on 02/06/25
-7.67 (-22.39%)
since 02/05/25
3-Month
26.17 +1.60%
on 03/04/25
Period Open: 42.28
44.22 -39.86%
on 12/09/24
-15.69 (-37.11%)
since 12/05/24
52-Week
26.17 +1.60%
on 03/04/25
Period Open: 54.47
66.54 -60.04%
on 05/07/24
-27.88 (-51.18%)
since 03/05/24

Most Recent Stories

More News
RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance

RXST : 26.59 (-1.01%)
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025

RXST : 26.59 (-1.01%)
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance

RXST : 26.59 (-1.01%)
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

RXST : 26.59 (-1.01%)
Insider Sale: See remarks of $RXST (RXST) Sells 3,105 Shares

Ilya Goldshleger, the See remarks of $RXST ($RXST), sold 3,105 shares of the company on 11-29-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.8% of their...

RXST : 26.59 (-1.01%)
Insider Sale: Director at $RXST (RXST) Sells 3,782 Shares

Shweta Maniar, a director at $RXST ($RXST), sold 3,782 shares of the company on 11-26-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 25.8% of their shares....

RXST : 26.59 (-1.01%)
RxSight, Inc. Reports Third Quarter 2024 Financial Results

RXST : 26.59 (-1.01%)
RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024

RXST : 26.59 (-1.01%)
3 Growth Stocks to Grab for 29% Upside or More

These three promising growth stocks could deliver upside of 29% or more, according to analysts’ estimates.

ZS : 196.45 (+1.36%)
NTNX : 77.10 (+0.03%)
RXST : 26.59 (-1.01%)
NVDA : 117.30 (+1.13%)
$SPX : 5,842.63 (+1.12%)
AZPN : 264.96 (+0.14%)
Chart of the Day: RxSight - Cashing In On Cataracts

The Chart of the Day belongs to the ophthalmic devices company RxSight (RXST) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals,...

RXST : 26.59 (-1.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

RxSight Inc. is a commercial-stage medical technology company focuses on patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens(R), RxSight Light Delivery Device and accessories. RxSight Inc. is based in ALISO VIEJO, Calif.

See More

Key Turning Points

3rd Resistance Point 27.77
2nd Resistance Point 27.42
1st Resistance Point 27.01
Last Price 26.59
1st Support Level 26.25
2nd Support Level 25.90
3rd Support Level 25.49

See More

52-Week High 66.54
Fibonacci 61.8% 51.12
Fibonacci 50% 46.35
Fibonacci 38.2% 41.59
Last Price 26.59
52-Week Low 26.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
How to Trade Futures Spreads Like a Pro – Unlock Powerful Market Insights